FuturHealth offers both compounded semaglutide and FDA-approved name-brand options like Wegovy and Ozempic. For most users, ...

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...

Researchers in Spain reported that halving the dose of Novo Nordisk's Wegovy weight-loss drug did not alter results.

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

In fact, you may have gotten more than a few targeted ads on social media from telehealth platforms selling these cheaper GLP ...

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

The U.S. Food and Drug Administration (FDA) has issued a warning to patients and healthcare professionals regarding the use ...

Ozempic for diabetes management is being widely talked about for its weight loss benefits. But it can also have side effects.